| An approach for identifiability of population pharmacokinetic–pharmacodynamic models V Shivva, J Korell, IG Tucker, SB Duffull CPT: pharmacometrics & systems pharmacology 2 (6), 1-9, 2013 | 48 | 2013 |
| A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells J Korell, LK Stamp, ML Barclay, JM Dalrymple, J Drake, M Zhang, ... Clinical pharmacokinetics 52, 475-485, 2013 | 24 | 2013 |
| Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis S Pan, LK Stamp, SB Duffull, ML Barclay, JM Dalrymple, J Drake, ... Clinical pharmacokinetics 53 (12), 1161-1170, 2014 | 22 | 2014 |
| Modeling red blood cell survival data J Korell, FE Vos, CV Coulter, JB Schollum, RJ Walker, SB Duffull Journal of pharmacokinetics and pharmacodynamics 38, 787-801, 2011 | 22 | 2011 |
| A statistical model for red blood cell survival J Korell, CV Coulter, SB Duffull Journal of theoretical biology 268 (1), 39-49, 2011 | 20 | 2011 |
| Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types J Korell, SB Duffull, JM Dalrymple, J Drake, M Zhang, ML Barclay, ... British Journal of Clinical Pharmacology 77 (3), 493-497, 2014 | 18 | 2014 |
| Evaluation of red blood cell labelling methods based on a statistical model for red blood cell survival J Korell, CV Coulter, SB Duffull Journal of theoretical biology 291, 88-98, 2011 | 18 | 2011 |
| Determination of plasma concentration reference ranges for oral aripiprazole, olanzapine, and quetiapine J Korell, B Green, A Rae, B Remmerie, A Vermeulen European Journal of Clinical Pharmacology 74, 593-599, 2018 | 17 | 2018 |
| Determination of plasma concentration reference ranges for risperidone and paliperidone J Korell, B Green, B Remmerie, A Vermeulen CPT: Pharmacometrics & Systems Pharmacology 6 (9), 589-595, 2017 | 13 | 2017 |
| A human challenge model for respiratory syncytial virus kinetics, the pharmacological effect of a novel fusion inhibitor, and the modelling of symptoms scores J Korell, B Green, J DeVincenzo, D Huntjens European Journal of Pharmaceutical Sciences 109, S154-S160, 2017 | 12 | 2017 |
| A model‐based longitudinal meta‐analysis of FEV1 in randomized COPD trials J Korell, SW Martin, MO Karlsson, J Ribbing Clinical Pharmacology & Therapeutics 99 (3), 315–324, 2016 | 12 | 2016 |
| Parameterisation affects identifiability of population models V Shivva, J Korell, IG Tucker, SB Duffull Journal of pharmacokinetics and pharmacodynamics 41, 81-86, 2014 | 8 | 2014 |
| A pharmacokinetic model for the glycation of albumin O Alskär, J Korell, SB Duffull Journal of pharmacokinetics and pharmacodynamics 39, 273-282, 2012 | 8 | 2012 |
| Optimizing Antipsychotic Patient Management Using Population Pharmacokinetic Models and Point‐of‐Care Testing B Green, J Korell, B Remmerie, A Savitz, A Vermeulen CPT: pharmacometrics & systems pharmacology 6 (9), 573-575, 2017 | 7 | 2017 |
| Simplification of a pharmacokinetic model for red blood cell methotrexate disposition S Pan, J Korell, LK Stamp, SB Duffull European journal of clinical pharmacology 71, 1509-1516, 2015 | 5 | 2015 |
| Bounded integer model‐based analysis of psoriasis area and severity index in patients with moderate‐to‐severe plaque psoriasis receiving BI 730357 QX Ooi, A Kristoffersson, J Korell, M Flack, E L. Plan, B Weber CPT: Pharmacometrics & Systems Pharmacology 12 (6), 758-769, 2023 | 4 | 2023 |
| Parametric time‐to‐event model for acute exacerbations in idiopathic pulmonary fibrosis F Tang, B Weber, S Stowasser, J Korell CPT: Pharmacometrics & Systems Pharmacology 9 (2), 87-95, 2020 | 4 | 2020 |
| A semi-mechanistic red blood cell survival model provides some insight into red blood cell destruction mechanisms J Korell, SB Duffull Journal of pharmacokinetics and pharmacodynamics 40, 469-478, 2013 | 4 | 2013 |
| Predicting Reductions in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations from FEV1-A Model-Based Meta-Analysis of Literature Data from Controlled Randomized Clinical … J Ribbing, J Korell, F Cerasoli, PA Milligan, SW Martin, MO Karlsson Journal of Pharmacokinetics and Pharmacodynamics 42 (S1), S63-S63, 2015 | 3 | 2015 |
| MODEL-BASED POPULATION ANALYSIS OF DISEASE PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS. T Vaidya, J Korell, B Weber, S Stowasser CLINICAL PHARMACOLOGY & THERAPEUTICS 107, S74-S74, 2020 | | 2020 |
Bruce GreenModel Answers, University of Queensland, BrightonПотвърден имейл адрес: model-a.com.au
